Primary record
Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor
- 库存
- 9,308 克
- 纯度
- 99.1 %
- CAS
- 396129-53-6
化合物标识与属性
- CAS
- 396129-53-6
- PubChem CID
- 447966
- SMILES
- C1=CC=C2C(=C1)C(=CC=N2)C3=C(NN=C3)C4=CC=CC=N4
- Canonical SMILES
- c1ccc(-c2[nH]ncc2-c2ccnc3ccccc23)nc1
名称与同义词
- 396129-53-6
- LY-364947
- LY364947
- TbetaR-I Inhibitor
- ALK5 Inhibitor I
- 4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)quinoline
- TGF-beta RI Kinase Inhibitor
- TGF-beta1 inhibitor
- 4-(3-PYRIDIN-2-YL-1H-PYRAZOL-4-YL)QUINOLINE
- LY 364947
- 1py5
- AC1L9LFY
- Peakdale1_000394
- RefChem:513399
- MFCD00800758
- D00SXR
- D0XB4P
- CHEMBL261454
- HTS 466284
- cc-654
- CHEBI:91198
- HTS-466284
- SCHEMBL373665
- 4-(5-pyridin-2-yl-1H-pyrazol-4-yl)quinoline
- GTPL6050
- Isoxazol-5-ylmethyl-methylamine
- orb1306643
- C17H12N4
- SCHEMBL21233972
- SCHEMBL29492641
- SCHEMBL29504909
- SCHEMBL29547877
- SCHEMBL30544879
- BDBM21492
- CHEBI:92118
- CTK1B3814
- HMS519B20
- AOB6754
- DTXSID90332266
- EX-A133
- Calbiochem catalog no. 616451
- HTS466284
- IBCXZJCWDGCXQT-UHFFFAOYSA-N
- 4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]quinoline
- BDBM747257
- GLXC-05063
- HMS2043N21
- HMS3229M09
- HMS3269P09
- HMS3648O10
- HMS3677D10
- HMS3742E17
- SM305
- BCP05350
- KS-00001D6O
- CID447966
- IN1053
- s2805
- ZINC15894680
- AKOS015854224
- AKOS025394671
- AKOS026750326
- BCP9000886
- CCG-206795
- CID:447966
- CS-3451
- DB03921
- PS-7269
- RL03518
- SB19489
- SDCCGSBI-0086715.P004
- NCGC00167839-01
- NCGC00167839-10
- NCGC00167839-15
- 4CA-0791
- AC-30262
- AJ-67976
- AJ-67977
- AK-35014
- BC600607
- DA-65152
- HY-13462
- SY062841
- 4-[3-(2-Pyridyl)-4-pyrazolyl]quinoline
- SID:163563914
- LY364947?
- Quinoline, 4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]-
- B2287
- FT-0676988
- NS00071287
- X5937
- [3-(Pyridin-2-yl)-4-(4-quinonyl)]-1H-pyrazole
- 4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]-quinoline
- 4-[5-(pyridin-2-yl)-1H-pyrazol-4-yl]quinoline
- EC-000.2417
- J2.037.928F
- 4-[3-(2-pyridyl)-1H-pyrazol-4-yl]quinoline
- 4-[5-(2-pyridyl)-1H-pyrazol-4-yl]quinoline
- A13446
- US20250179094, Compound LY364947
- Z-3279
- 3-(2-Pyridinyl)-4-(4-quinolinyl)-1H-pyrazole
- 4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]quinoline
- LY-364947, >=98% (HPLC)
- 3-(Pyridin-2-yl)-4-(4-quinonyl)]-1H-pyrazole
- 4-(3-pyridin-2-yl)(1h)-pyrazol-4-yl quinoline
- 4-[3-(2-Pyridinyl)-1H-pyrazole-4-yl]quinoline
- A873615
- C506615
- C520284
- F023739
- I08-901
- SR-01000385325
- 4-[(3-Pyridin-2-yl)-1H-pyrazol-4-yl)]quinoline
- SR-01000385325-1
- SR-01000385325-2
- 4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]??-quinoline
- BRD-K06234293-001-01-8
- BRD-K06234293-001-03-4
- BRD-K06234293-001-04-2
- Q27088977
- Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor
- B1370-353667
- PY1